ARCHIVE

• Takeda: 4 Global Strategic Products Saw Continued Growth in 3rd Qtr
  February 10, 2003

• BULLTIN
  February 10, 2003

• CORPORATE ROUNDUP NEWS IN BRIEF
  February 10, 2003

• 100% Acquisition to Eliminate Wall Between Merck, Banyu
  February 10, 2003

• Chuikyo to Discuss Additional NHI Price Cuts for Long-listed Original Drugs
  February 10, 2003

• GSK, Sankyo Agree to Copromote Type 2 Diabetes Drug, Rosiglitazone
  February 10, 2003

• Korosho to Start Disease-related Protein Analysis Project
  February 10, 2003

• METI to Promote Health Service Industries to Cut Medical Costs
  February 3, 2003

• DIAGNOSTIC NEWS IN BRIEF
  February 3, 2003

• Chuikyo Subcommittee to Start Talks on NHI Price System in March
  February 3, 2003

• Kyowa Hakko Licenses Oral DDS Tablet Technology to Eurand
  February 3, 2003

• REGULATORY NEWS IN BRIEF
  February 3, 2003

• New Nursing Care Fees to Promote Self-support, Home Care
  February 3, 2003

• JMA Demands Korosho Not Raise Copayment to 30%
  February 3, 2003

• Teijin to Integrate Medical, Pharma Business with Kyorin
  February 3, 2003

• Nat'l Univ. Hospitals Submit Petition on Fiscal Management
  February 3, 2003

• WORLD NEWS IN BRIEF
  February 3, 2003

• Chugai to Start Worldwide PIII Trials of MRA for RA
  February 3, 2003

• Taiho Licenses IPD-1151T to Yamanouchi in Urology
  February 3, 2003

• Use of Thalidomide at Physician's Discretion, Patient's Wishes Risky
  February 3, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 621
• 622
• 623
• 624
• 625
• 626
• 627
• 628
• 629
• …
• Next ›
• 最終 »